CompaniesNotable Labs

Notable Labs

defunct
About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

2

As Collaborator

2

Total Enrollment

302

By Status

COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT04014764
NCT04263181
NCT05245032
Hover over trial bars to see details

Recent Trials

NCT06566911Lead Sponsor
Voice Analysis for Monitoring Patients With Heart Failure
N/ARecruiting
70 participants
Started: Jan 24, 2024 · Completed: Sep 30, 2024
NCT05245032Collaborator
Biologically Focused Therapy of Treatment-Refractory MDS Patients
N/ACompleted
33 participants
Started: Feb 18, 2020 · Completed: Dec 1, 2022
NCT04263181Collaborator
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
N/AActive, not recruiting
80 participants
Started: Jan 29, 2020 · Completed: Jan 31, 2026
NCT04014764Lead Sponsor
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
N/ACompleted
119 participants
Started: Dec 15, 2019 · Completed: Mar 31, 2022
Funding History (6)
D
Mar 8, 2023
Filing
D
Jul 15, 2022
Filing
D
Dec 13, 2019
Filing
D
Aug 31, 2017
Filing
D
Mar 16, 2017
Filing
D
May 17, 2016
Filing
Related Companies
Vbl Therapeutics
merged